Biotechnology and Development ApS: Financial statements 2025
CVR: 33870639
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 282,184 and a net result of DKK -1,709 compared with DKK 66,166 the year before. That is an increase of 162.3% compared with the year before. Equity in the 2025 report amounted to DKK 105,217. The solvency ratio was 51.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 282,184
- Profit/Loss
- DKK -1,709
- Equity
- DKK 105,217
- Total Assets
- DKK 205,192
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 282 t. | -2 t. | 105 t. | 1 |
| 2024 | - | 108 t. | 66 t. | 107 t. | 1 |
| 2023 | - | 3 t. | -15 t. | 41 t. | 1 |
| 2022 | - | 45 t. | 19 t. | 55 t. | 1 |
| 2021 | - | -7 t. | -22 t. | 36 t. | 1 |
Official annual report
How creditworthy is Biotechnology and Development ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2026, the company reported a gross profit of DKK 268,463 and a net result of DKK -54,610 compared with DKK -1,709 the year before. Equity in the 2026 report amounted to DKK 50,608.